Intellego enters negotiations with global pharma group
Intellego has initiated negotiations with one of the world’s largest companies in the pharmaceutical consumables and production sector. This US-based company has over 10,000 employees and operates in more than 150 countries. It is a subsidiary of one of the world’s leading pharmaceutical groups, which employs over 80,000 people globally.
The company has spent the past nine months evaluating Intellego’s UV LED dosimeters and the market, yielding positive results. The aim of this collaboration is to launch Intellego’s UV LED dosimeters, and potentially other dosimeter products, on the global market which has an estimated value of EUR 2 billion per year.
The launch is planned for 2025, with sales expected to increase progressively over time.
